<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">genort</journal-id><journal-title-group><journal-title xml:lang="ru">Гений ортопедии</journal-title><trans-title-group xml:lang="en"><trans-title>Genij Ortopedii</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1028-4427</issn><issn pub-type="epub">2542-131X</issn><publisher><publisher-name>ЦЕНТР ИЛИЗАРОВА</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18019/1028-4427-2021-27-1-55-58</article-id><article-id custom-type="elpub" pub-id-type="custom">genort-2601</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Оригинальные статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Original articles</subject></subj-group></article-categories><title-group><article-title>Опыт артроскопической хирургии при тофусной подагре: показания, результаты и осложнения</article-title><trans-title-group xml:lang="en"><trans-title>Experience of arthroscopic surgery in tophaceous gout: indications, results and complications</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8560-1870</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Tan</surname><given-names>W.</given-names></name><name name-style="western" xml:lang="en"><surname>Tan</surname><given-names>W.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Wei Tan, M.D., Ph.D.,</p><p>Chengdu city, Sichuan Province</p></bio><bio xml:lang="en"><p>Wei Tan, M.D., Ph.D.,</p><p>Chengdu city, Sichuan Province</p></bio><email xlink:type="simple">tw18181420391@163.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2538-2132</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Chen</surname><given-names>J.</given-names></name><name name-style="western" xml:lang="en"><surname>Chen</surname><given-names>J.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Jianchun Chen, M.D.,</p><p>Chengdu city, Sichuan Province</p></bio><bio xml:lang="en"><p>Jianchun Chen, M.D.,</p><p>Chengdu city, Sichuan Province</p></bio><email xlink:type="simple">cjc18030541834@163.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9835-1188</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ran</surname><given-names>R.</given-names></name><name name-style="western" xml:lang="en"><surname>Ran</surname><given-names>R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ran Ran, M.D.,</p><p>Chengdu city, Sichuan Province</p></bio><bio xml:lang="en"><p>Ran Ran, M.D.,</p><p>Chengdu city, Sichuan Province</p></bio><email xlink:type="simple">rr19181737867@163.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5133-9472</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Zheng</surname><given-names>W.</given-names></name><name name-style="western" xml:lang="en"><surname>Zheng</surname><given-names>W.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Wuyan Zheng, M.D.,</p><p>Chengdu city, Sichuan Province</p></bio><bio xml:lang="en"><p>Wuyan Zheng, M.D.,</p><p>Chengdu city, Sichuan Province</p></bio><email xlink:type="simple">1642637460@qq.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8027-5693</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Oshmianska</surname><given-names>N.</given-names></name><name name-style="western" xml:lang="en"><surname>Oshmianska</surname><given-names>N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Nataliia Oshmianska, M.D.,</p><p>Chengdu city, Sichuan Province</p></bio><bio xml:lang="en"><p>Nataliia Oshmianska, M.D.,</p><p>Chengdu city, Sichuan Province</p></bio><email xlink:type="simple">1283182076@qq.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Chengdu Rheumatism Hospital</institution><country>Китай</country></aff><aff xml:lang="en"><institution>Chengdu Rheumatism Hospital</institution><country>China</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>28</day><month>02</month><year>2021</year></pub-date><volume>27</volume><issue>1</issue><issue-title>№ 1 (2021)</issue-title><fpage>55</fpage><lpage>58</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Tan W., Chen J., Ran R., Zheng W., Oshmianska N., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Tan W., Chen J., Ran R., Zheng W., Oshmianska N.</copyright-holder><copyright-holder xml:lang="en">Tan W., Chen J., Ran R., Zheng W., Oshmianska N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.ilizarov-journal.com/jour/article/view/2601">https://www.ilizarov-journal.com/jour/article/view/2601</self-uri><abstract><sec><title>Актуальность</title><p>Актуальность. Подагра, развивающаяся в течение 5 лет и более, и высокие неконтролируемые уровни мочевой кислоты в крови приводят к образованию тофиподагрических камней, содержащих кристаллы УК, окруженные соединительной тканью. В результате образования тофусов в области сустава пациенты испытывают значительный дискомфорт и нередко полностью теряют трудоспособность.</p></sec><sec><title>Цель</title><p>Цель. Определить показания к хирургическому лечению при подагре в Ревматологической больнице Чэнду, оценить результаты и осложнения, а также эффективность нового хирургического оборудования.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Показания и результаты хирургического вмешательства при подагре, выполненного в Ревматологической больнице Чэнду в 2019–2020 гг., были исследованы у 63 пациентов мужского пола. Ретроспективный анализ был проведен на основании медицинских карт пациентов, которым была назначена уратснижающая терапия и выполнено артроскопическое или сложное хирургическое вмешательство, сочетающее артроскопическую обработку с процедурой открытой тофэктомии.</p></sec><sec><title>Результаты</title><p>Результаты. Наиболее частыми очагами поражения были суставы стопы и пальцев ног (49,41 %), голеностопный (39,68 %) и коленный сустав (34,92 %) с их ограниченной подвижностью. Среди распространенных жалоб были невозможность выполнять повседневную деятельность из-за увеличенных в размерах суставов (невозможность носить обувь), их дисфункция и боли. У более молодых пациентов в возрасте 20-44 лет до лечения уровень мочевой кислоты в сыворотке был значительно выше. В большинстве случаев показаниями к операции в этой группе пациентов были боли и дискомфорт в суставах, невозможность выполнять повседневную работу. После определения степени боли 38,46 % более молодых пациентов сообщили об уровне боли 6 или выше по шкале ВАШ, что было чаще, чем у пациентов в возрасте 45–55 лет (26,92 %) и старше 55 лет (10,0 %). После операции и уратснижающей терапии все пациенты отметили функциональное улучшение и уменьшение боли. Снижение уровня уратов в сыворотке было зарегистрировано у 96,83 % пациентов.</p></sec><sec><title>Заключение</title><p>Заключение. Результаты хирургического лечения функциональных нарушений (неспособность выполнять повседневную деятельность из-за ограниченного диапазона движений) и массивной трансформации суставов (невозможность носить обувь/одежду) у больных подагрой были положительными. Все пациенты сообщают о функциональном улучшении, уменьшении боли и минимальном риске осложнений. В дополнение к уратснижающей терапии мы рекомендуем проводить артроскопическую чистку осторожно даже у более молодых пациентов с подагрой в соответствии с вышеупомянутыми показаниями. </p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Background</title><p>Background. Gout, lasting 5 years or more, and high uncontrollable levels of uric acid in blood lead to the formation of tophi – gouty stones containing the UA crystals surrounded with connective tissue. As the result of tophi formation in the joint area patients felt extreme discomfort and quite often completely lose ability to work.</p></sec><sec><title>Objectives</title><p>Objectives. To define indications for tophaceous gout surgery in the Chengdu Rheumatism Hospital, evaluate surgical results and complications, as well as the effectiveness of a new surgery equipment.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The indications and results of tophaceous gout surgery were investigated in 63 male gout patients of Chengdu Rheumatism hospital in 2019-2020. A retrospective analysis was carried out on the basis of medical records for all patients who were prescribed with urate lowering therapy and underwent arthroscopic intervention or complex surgical intervention combining arthroscopic shaving with open tophectomy procedure.</p></sec><sec><title>Results</title><p>Results. The most common lesion site was foot joints: toes (49.41 %), ankle (39.68 %) and knee (34.92 %), with restricted mobility in the mentioned joints. Among common complaints were inability to perform daily routines due to enlarged joints (inability to wear shoes), joints’ dysfunction and pain. Younger patients (aged 20–44) had significantly higher levels of uric acid in serum before treatment. In most cases, indications for surgery for this group of patients were pain and discomfort in joints, inability to perform daily work. After accessing pain levels, 38.46 % of younger patients reported pain leveled 6 or higher on VAS score, which was more often, compared to patients aged 45–55 (26.92 %) and older than 55 (10.0 %). After surgery and following urate lowering therapy all patients noted functional improvement and reduction of pain. Decrease in serum urate levels were reported in 96.83 % of patients.</p></sec><sec><title>Conclusion</title><p>Conclusion. The results of surgical treatment for functional impairment of the joint (inability to perform daily work due to restricted range of motions) and massive joint transformation (inability to wear shoes/clothes) in gout patients are positive, with all patients reporting functional improvement and reduction of pain, and the risk of complications is low. In addition to urate lowering therapy we cautiously recommend performing arthroscopic shaving even in younger gout patients consistent with aforementioned indications.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>подагра</kwd><kwd>гиперурикемия</kwd><kwd>тофусы</kwd><kwd>артроскопическая обработка</kwd></kwd-group><kwd-group xml:lang="en"><kwd>gout</kwd><kwd>hyperuricemia</kwd><kwd>tophi</kwd><kwd>arthroscopic shaving</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Mandell B.F. Clinical manifestations of hyperuricemia and gout. Cleve Clin. J. Med., 2008, no. 75 Suppl 5, pp. S5-S8. DOI: 10.3949/ccjm.75.suppl_5.s5</mixed-citation><mixed-citation xml:lang="en">Mandell B.F. Clinical manifestations of hyperuricemia and gout. Cleve Clin. J. Med., 2008, no. 75 Suppl 5, pp. S5-S8. DOI: 10.3949/ccjm.75.suppl_5.s5</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Dehlin M., Jacobsson L., &amp; Roddy E. Global epidemiology of gout: Prevalence, incidence, treatment patterns and risk factors. at. Rev. Rheumatol., 2020, Vol. 16, no. 7, pp. 380-390.</mixed-citation><mixed-citation xml:lang="en">Dehlin M., Jacobsson L., &amp; Roddy E. Global epidemiology of gout: Prevalence, incidence, treatment patterns and risk factors. at. Rev. Rheumatol., 2020, Vol. 16, no. 7, pp. 380-390.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">McLean L., Becker M. Etiology and pathogenesis of gout. In: M.C. Hochberg, A.J. Silman, J.S. Smolen, M.E. Weinblatt, M.H. Weisman, eds. Rheumatology. Elsevier Ltd., Mosby, 2011, Section 14, No 187, pp. 1555.</mixed-citation><mixed-citation xml:lang="en">McLean L., Becker M. Etiology and pathogenesis of gout. In: M.C. Hochberg, A.J. Silman, J.S. Smolen, M.E. Weinblatt, M.H. Weisman, eds. Rheumatology. Elsevier Ltd., Mosby, 2011, Section 14, No 187, pp. 1555.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Puig J.G., Martínez M.A. Hyperuricemia, gout and the metabolic syndrome. Curr. Opin. Rheumatol., 2008, vol. 20, no. 2, pp. 187-191. DOI: 10.1097/BOR.0b013e3282f4b1ed</mixed-citation><mixed-citation xml:lang="en">Puig J.G., Martínez M.A. Hyperuricemia, gout and the metabolic syndrome. Curr. Opin. Rheumatol., 2008, vol. 20, no. 2, pp. 187-191. DOI: 10.1097/BOR.0b013e3282f4b1ed</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Khanna P.P., Nuki G., Bardin T., Tausche A.K., Forsythe A., Goren A., Vietri J., Khanna D. Tophi and frequent gout flares are associated with impairmentsto quality of life, productivity, and increased healthcare resource use: Resultsfrom a cross-sectionalsurvey. Health Qual. Life Outcomes, 2012, vol. 10, pp. 117. DOI: 10.1186/1477-7525-10-117</mixed-citation><mixed-citation xml:lang="en">Khanna P.P., Nuki G., Bardin T., Tausche A.K., Forsythe A., Goren A., Vietri J., Khanna D. Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey. Health Qual. Life Outcomes, 2012, vol. 10, pp. 117. DOI: 10.1186/1477-7525-10-117</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">McQueen F.M., Chhana A., Dalbeth N. Mechanisms of joint damage in gout: evidence from cellular and imaging studies. Nat. Rev. Rheumatol., 2012, vol. 8, no. 3, pp. 173-181. DOI: 10.1038/nrrheum.2011.207</mixed-citation><mixed-citation xml:lang="en">McQueen F.M., Chhana A., Dalbeth N. Mechanisms of joint damage in gout: evidence from cellular and imaging studies. Nat. Rev. Rheumatol., 2012, vol. 8, no. 3, pp. 173-181. DOI: 10.1038/nrrheum.2011.207</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ragab G., Elshahaly M., Bardin T. Gout: An old disease in new perspective – a review. J. Adv. Res., 2017, vol. 8, no. 5, pp. 495-511. DOI: 10.1016/j.jare.2017.04.008</mixed-citation><mixed-citation xml:lang="en">Ragab G., Elshahaly M., Bardin T. Gout: An old disease in new perspective – a review. J. Adv. Res., 2017, vol. 8, no. 5, pp. 495-511. DOI: 10.1016/j.jare.2017.04.008</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kasper I.R., Juriga M.D., Giurini J.M., Shmerling R.H. Treatment of tophaceous gout: When Medication is not enough. Semin. Arthritis Rheum., 2016, vol. 45, no. 6, pp. 669-674. DOI: 10.1016/j.semarthrit.2016.01.005</mixed-citation><mixed-citation xml:lang="en">Kasper I.R., Juriga M.D., Giurini J.M., Shmerling R.H. Treatment of tophaceous gout: When Medication is not enough. Semin. Arthritis Rheum., 2016, vol. 45, no. 6, pp. 669-674. DOI: 10.1016/j.semarthrit.2016.01.005</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Kumar S., Gow P. A survey of indications, results and complications of surgery for tophaceous gout. N. Z. Med. J., 2002, vol. 115, no. 1158, pp. U109.</mixed-citation><mixed-citation xml:lang="en">Kumar S., Gow P. A survey of indications, results and complications of surgery for tophaceous gout. N. Z. Med. J., 2002, vol. 115, no. 1158, pp. U109.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Wang C.C., Lien S.B., Huang G.S., Pan R.Y., Shen H.C., Kuo C.L., Shen P.H., Lee C.H. Arthroscopic elimination of monosodium urate deposition of the first metatarsophalangeal joint reduces the recurrence of gout. Arthroscopy, 2009, vol. 25, no. 2, pp. 153-158. DOI: 10.1016/j.arthro.2008.09.002</mixed-citation><mixed-citation xml:lang="en">Wang C.C., Lien S.B., Huang G.S., Pan R.Y., Shen H.C., Kuo C.L., Shen P.H., Lee C.H. Arthroscopic elimination of monosodium urate deposition of the first metatarsophalangeal joint reduces the recurrence of gout. Arthroscopy, 2009, vol. 25, no. 2, pp. 153-158. DOI: 10.1016/j.arthro.2008.09.002</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Khanna D., Fitzgerald J.D., Khanna P.P., Bae S., Singh M.K., Neogi T., Pillinger M.H., Merill J., Lee S., Prakash S., Kaldas M., Gogia M., PerezRuiz F., Taylor W., Lioté F., Choi H., Singh J.A., Dalbeth N., Kaplan S., Niyyar V., Jones D., Yarows S.A., Roessler B., Kerr G., King C., Levy G., Furst D.E., Edwards N.L., Mandell B., Schumacher H.R., Robbins M., Wenger N., Terkeltaub R.; American College of Rheumatology. American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res. (Hoboken), 2012, vol. 64, no. 10, pp. 1431-1446. DOI: 10.1002/acr.21772</mixed-citation><mixed-citation xml:lang="en">Khanna D., Fitzgerald J.D., Khanna P.P., Bae S., Singh M.K., Neogi T., Pillinger M.H., Merill J., Lee S., Prakash S., Kaldas M., Gogia M., Perez-Ruiz F., Taylor W., Lioté F., Choi H., Singh J.A., Dalbeth N., Kaplan S., Niyyar V., Jones D., Yarows S.A., Roessler B., Kerr G., King C., Levy G., Furst D.E., Edwards N.L., Mandell B., Schumacher H.R., Robbins M., Wenger N., Terkeltaub R.; American College of Rheumatology. American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res. (Hoboken), 2012, vol. 64, no. 10, pp. 1431-1446. DOI: 10.1002/acr.21772</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Edwards N.L. Treatment-failure gout: a moving target. Arthritis Rheum., 2008, vol. 58, no. 9, pp. 2587-2590. DOI: 10.1002/art.23803</mixed-citation><mixed-citation xml:lang="en">Edwards N.L. Treatment-failure gout: a moving target. Arthritis Rheum., 2008, vol. 58, no. 9, pp. 2587-2590. DOI: 10.1002/art.23803</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Lee S.S., Chen M.C., Chou Y.H., Lin S.D., Lai C.S., Chen Y.C. Timing of intra-lesion shaving for surgical treatment of chronic tophus. J. Plast. Reconstr. Aesthet. Surg., 2013, vol. 66, no. 8, pp. 1131-1137. DOI: 10.1016/j.bjps.2013.03.041</mixed-citation><mixed-citation xml:lang="en">Lee S.S., Chen M.C., Chou Y.H., Lin S.D., Lai C.S., Chen Y.C. Timing of intra-lesion shaving for surgical treatment of chronic tophus. J. Plast. Reconstr. Aesthet. Surg., 2013, vol. 66, no. 8, pp. 1131-1137. DOI: 10.1016/j.bjps.2013.03.041</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Öztürk R., Atalay İ.B., Bulut E.K., Beltir G., Yılmaz S., Güngör B.Ş. Place of orthopedic surgery in gout. Eur. J. Rheumatol., 2019, vol. 6, no. 4, pp. 212-215. DOI: 10.5152/eurjrheum.2019.19060</mixed-citation><mixed-citation xml:lang="en">Öztürk R., Atalay İ.B., Bulut E.K., Beltir G., Yılmaz S., Güngör B.Ş. Place of orthopedic surgery in gout. Eur. J. Rheumatol., 2019, vol. 6, no. 4, pp. 212- 215. DOI: 10.5152/eurjrheum.2019.19060</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Atakhanova L.E., Tsurko V.V., Buleva I.M., Boiko I.N., Zheleznov S.P., Ivanova T.B. Podagra: Ot etiologii i patogeneza k diagnostike i ratsionalnoi farmakoterapii [Gout: From etiology and pathogenesis to diagnosis and rational pharmacotherapy]. Sovremennaia Revmatologiia, 2007, vol. 1, no. 1, pp. 13-18. (in Russian) DOI: 10.14412/1996-7012-2007-433</mixed-citation><mixed-citation xml:lang="en">Atakhanova L.E., Tsurko V.V., Buleva I.M., Boiko I.N., Zheleznov S.P., Ivanova T.B. Podagra: Ot etiologii i patogeneza k diagnostike i ratsionalnoi farmakoterapii [Gout: From etiology and pathogenesis to diagnosis and rational pharmacotherapy]. Sovremennaia Revmatologiia, 2007, vol. 1, no. 1, pp. 13-18. (in Russian) DOI: 10.14412/1996-7012-2007-433</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
